BiotechTube

Simultaneous administration of Pneumovax NP® and Fluvic HA syringe® + Sequential administration of Pneumovax NP® and Fluvic HA syringe®

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Pneumococcal Pneumonia

Conditions

Pneumococcal Pneumonia, Influenza

Trial Timeline

Nov 1, 2015 → Aug 1, 2016

NCT ID
NCT02592486

About Simultaneous administration of Pneumovax NP® and Fluvic HA syringe® + Sequential administration of Pneumovax NP® and Fluvic HA syringe®

Simultaneous administration of Pneumovax NP® and Fluvic HA syringe® + Sequential administration of Pneumovax NP® and Fluvic HA syringe® is a approved stage product being developed by Merck for Pneumococcal Pneumonia. The current trial status is completed. This product is registered under clinical trial identifier NCT02592486. Target conditions include Pneumococcal Pneumonia, Influenza.

What happened to similar drugs?

14 of 20 similar drugs in Pneumococcal Pneumonia were approved

Approved (14) Terminated (1) Active (6)
✅PNEUMOVAX™ 23MerckApproved
✅21-valent pneumococcal conjugate vaccineMerckApproved
✅ProDiax-23 (PPSV23)MerckApproved
✅13-valent pneumococcal conjugate vaccine + 13-valent pneumococcal conjugate vaccinePfizerApproved
✅pneumococcus conjugate vaccine 7 valent to reduce carriagePfizerApproved
✅pneumococcus conjugate vaccinePfizerApproved
✅PrevenarPfizerApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02592486ApprovedCompleted

Competing Products

20 competing products in Pneumococcal Pneumonia

See all competitors
ProductCompanyStageHype Score
V116 + PPSV23MerckPhase 3
40
V114 + QIV + Matching Placebo for V114MerckPhase 3
40
V114 + Prevnar 13™ + PNEUMOVAX™23MerckPhase 3
40
V114 Lot 1 + V114 Lot 2 + Prevnar 13™MerckPhase 2
35
PNEUMOVAX™ 23MerckApproved
43
Pneumococcal Vaccine, Polyvalent (23-valent)MerckPhase 3
40
V114 + Prevnar 13™ + PNEUMOVAX™23MerckPhase 3
40
V114 + Prevnar 13®MerckPhase 3
40
V114 Medium Dose + V114 High Dose + V114 Medium Dose with Alternative Carrier Protein + V114 High Dose with Alternative Carrier Protein + Prevnar 13™MerckPhase 1/2
32
V116 + PPSV23MerckPhase 3
40
V114MerckPhase 3
40
Prevnar 13™ + V114 + RotaTeq™ + Pentacel™ + RECOMBIVAX HB™ + HIBERIX™ + M-M-R™ II + VARIVAX™MerckPhase 3
40
V114 + Prevnar 13®MerckPhase 3
40
Pneumococcal Conjugate Vaccine (V114) + PNEUMOVAX® 23 + PREVNAR 13®MerckPhase 2
35
V114-A + V114-B + Prevnar 13®MerckPhase 2
35
V116 + Pneumovax™23MerckPhase 1/2
32
V114 + Prevnar 13™MerckPhase 3
40
V114 + Prevnar 13™MerckPhase 2
35
21-valent pneumococcal conjugate vaccineMerckApproved
50
V116 + PPSV23MerckPhase 3
40